Jeffrey M. DRAZEN, M.D.

DrazenSenior Physician, Brigham and Women’s Hospital
Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School
Professor of Physiology, Harvard School of Public Health
Adjunct Professor of Medicine, Boston University School of Medicine
Editor-in Chief, New England Journal of Medicine

Education:
Bachelor in Applied Physics: Tufts University
M.D. Degree: Harvard Medical School

Research Interests:
• Active researcher in the field of pulmonary medicine
• Definition of the role of novel endogenous chemical agents in asthma
• Mechanical transduction in the airways

Bio:
Born and raised in Clayton, Missouri, Dr. Drazen majored in applied physics at Tufts University and graduated from Harvard Medical School in 1972. He served his medical internship and residency at Peter Bent Brigham Hospital in Boston and was a clinical fellow and a research fellow at Harvard Medical School and the Harvard School of Public Health. Thereafter, he served as chief of Pulmonary Medicine at the Beth Israel Hospital, chief of the combined Pulmonary Divisions of the Beth Israel and Brigham and Women’s Hospitals, and then as chief of Pulmonary Medicine at Brigham and Women’s Hospital. Dr. Drazen currently holds the positions of senior physician at the Brigham and Women’s Hospital, Distinguished Parker B. Francis Professor of Medicine at Harvard Medical School, professor of physiology at the Harvard School of Public Health and adjunct professor of medicine at the Boston University School of Medicine. He is the recipient of honorary degrees from the University of Ferrara and the University of Athens. Dr. Drazen has worked with the National Institutes of Health in a variety of capacities, including its Respiratory and Applied Physiology Study Section, Pulmonary Disease Advisory Council, Lung Biology and Pathology Study Section, National Heart, Lung and Blood Institute Advisory Council and the National Library of Medicine Public Access Working Group. He has also served on the Veterans’ Administration National Research Advisory Council. Dr. Drazen is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, the Inter-Urban Clinical Club and the Institute of Medicine. He currently co-chairs the Institute of Medicine’s Forum on Drug Discovery, Development, and Translation and is a member of the World Health Organization’s Scientific Advisory Group on Clinical Trials Registration. An active researcher in the field of pulmonary medicine, Dr. Drazen defined the role of novel endogenous chemical agents in asthma. This led to four new licensed pharmaceuticals for asthma, now used in the treatment of millions of people worldwide. He has published over 500 papers, editorials and review articles and has edited six books, including Cecil Medicine and Asthma and COPD.

Publications extlink